Re-establishing self-tolerance by targeting MHC class II-restricted autoimmunity
Juvenile diabetes is an autoimmune disease resulting from an attack that destroys pancreatic cells that secrete insulin. Javier Clemente Casares is studying a therapeutic approach that could lead to a nanovaccine for the disease.
University of Calgary
A nanovaccine for juvenile diabetes
To add or modify information on this page, please contact us at the following address: firstname.lastname@example.org